EXACT SCIENCES CORP — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| ORVILLE JACOB A | EVP, GM, Screening | Option Exercise | 28,779 | — | — | Dec 23, 2025 |
| Baranick Brian | EVP, GM, Precision Oncology | Option Exercise | 3,955 | — | — | Dec 23, 2025 |
| Condella Sarah | EVP, Human Resources | Award / Grant | 8,000 | — | — | Dec 23, 2025 |
| Conroy Kevin T | President and CEO | Award / Grant | 244,931 | — | — | Dec 23, 2025 |
| Herriott James | SVP, General Counsel & Sec | Option Exercise | 13,893 | — | — | Dec 23, 2025 |
| Bloomer Aaron | EVP, Chief Financial Officer | Tax Withholding | 10,803 | $101.82 | $1,099,961 | Dec 23, 2025 |
| ORVILLE JACOB A | EVP, GM, Screening | Sale | 5,000 | $75.00 | $375,000 | Nov 19, 2025 |
| Herriott James | SVP, General Counsel & Sec | Sale | 1,000 | $70.00 | $70,000 | Nov 19, 2025 |
| Herriott James | SVP, General Counsel & Sec | Sale | 1,500 | $70.08 | $105,120 | Nov 4, 2025 |
| Baranick Brian | EVP, GM, Precision Oncology | Sale | 2,858 | $70.08 | $200,289 | Nov 4, 2025 |
| Zanotti Katherine S | — | Sale | 12,000 | $65.00 | $780,000 | Oct 24, 2025 |
| Herriott James | SVP, General Counsel & Sec | Sale | 1,500 | $60.00 | $90,000 | Oct 9, 2025 |
| Doyle James Edward | — | Sale | 2,000 | $60.00 | $120,000 | Oct 9, 2025 |
| Doyle James Edward | — | Sale | 1,485 | $42.02 | $62,400 | Aug 13, 2025 |
| ORVILLE JACOB A | EVP, GM, Screening | Tax Withholding | 2,515 | $46.83 | $117,777 | Aug 5, 2025 |
| Baranick Brian | EVP, GM, Precision Oncology | Tax Withholding | 2,717 | $46.83 | $127,237 | Aug 5, 2025 |
| Zanotti Katherine S | — | Award / Grant | 5,398 | — | — | Jun 13, 2025 |
| Doyle James Edward | — | Award / Grant | 5,398 | — | — | Jun 12, 2025 |
| Barber Michael J | — | Award / Grant | 7,197 | — | — | Jun 12, 2025 |
| Clancy Paul J | — | Award / Grant | 5,398 | — | — | Jun 12, 2025 |
| Popovits Kimberly J | — | Award / Grant | 9,994 | — | — | Jun 12, 2025 |
| Trigg Leslie | — | Award / Grant | 7,670 | — | — | Jun 12, 2025 |
| Petrovic Shacey | — | Award / Grant | 5,398 | — | — | Jun 12, 2025 |
| LEVANGIE DANIEL J | — | Award / Grant | 5,398 | — | — | Jun 12, 2025 |
| COWARD D SCOTT | — | Award / Grant | 5,398 | — | — | Jun 12, 2025 |
| Herriott James | SVP, General Counsel & Sec | Award / Grant | 363 | $38.26 | $13,888 | Apr 30, 2025 |
| Trigg Leslie | — | Award / Grant | 8,527 | — | — | Apr 29, 2025 |
| Bloomer Aaron | EVP, Chief Financial Officer | Option Exercise | 11,556 | — | — | Apr 15, 2025 |
| Conroy Kevin T | President and CEO | Option Exercise | 66,723 | $22.38 | $1,493,261 | Mar 7, 2025 |
| Herriott James | SVP, General Counsel & Sec | Tax Withholding | 889 | $47.82 | $42,512 | Feb 28, 2025 |
| Conroy Kevin T | President and CEO | Option Exercise | 18,143 | — | — | Feb 28, 2025 |
| Baranick Brian | EVP, GM, Precision Oncology | Tax Withholding | 2,513 | $47.82 | $120,172 | Feb 28, 2025 |
| ORVILLE JACOB A | EVP, GM, Screening | Tax Withholding | 2,326 | $47.82 | $111,229 | Feb 28, 2025 |
| Condella Sarah | EVP, Human Resources | Tax Withholding | 1,861 | $47.82 | $88,993 | Feb 28, 2025 |
| Condella Sarah | EVP, Human Resources | Tax Withholding | 1,859 | $51.28 | $95,330 | Feb 25, 2025 |
| Baranick Brian | EVP, GM, Precision Oncology | Tax Withholding | 2,008 | $51.28 | $102,970 | Feb 25, 2025 |
| Herriott James | SVP, General Counsel & Sec | Option Exercise | 1,647 | — | — | Feb 25, 2025 |
| ORVILLE JACOB A | EVP, GM, Screening | Option Exercise | 3,954 | — | — | Feb 25, 2025 |
| Conroy Kevin T | President and CEO | Option Exercise | 13,180 | — | — | Feb 25, 2025 |
| Conroy Kevin T | President and CEO | Award / Grant | 48,044 | — | — | Feb 20, 2025 |
| ORVILLE JACOB A | EVP, GM, Screening | Option Exercise | 2,248 | — | — | Feb 20, 2025 |
| Herriott James | SVP, General Counsel & Sec | Tax Withholding | 433 | $49.63 | $21,490 | Feb 20, 2025 |
| Baranick Brian | EVP, GM, Precision Oncology | Tax Withholding | 968 | $49.63 | $48,042 | Feb 19, 2025 |
| Condella Sarah | EVP, Human Resources | Tax Withholding | 2,214 | $50.48 | $111,763 | Feb 19, 2025 |
| COWARD D SCOTT | — | Option Exercise | 2,248 | — | — | Feb 19, 2025 |
| Popovits Kimberly J | — | Award / Grant | 6,387 | — | — | Jan 2, 2025 |
| Conroy Kevin T | President and CEO | Purchase | 19,500 | $51.35 | $1,001,325 | Nov 13, 2024 |
| Baranick Brian | EVP, GM, Precision Oncology | Sale | 929 | $70.00 | $65,030 | Oct 8, 2024 |
| Baranick Brian | EVP, GM, Precision Oncology | Sale | 929 | $70.00 | $65,030 | Sep 18, 2024 |
| Baranick Brian | EVP, GM, Precision Oncology | Tax Withholding | 1,375 | $55.77 | $76,684 | Aug 5, 2024 |